Skip to content

ANI Pharmaceuticals ANIP Gross Carrying Amount

Gross Carrying Amount at other companies

Viatris logo
ViatrisVTRS
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
Cardinal Health logo
Cardinal HealthCAH
Pfizer logo
PfizerPFE
Amgen logo
AmgenAMGN

Other financials

Income statement

See full
Revenue$237.5M+20.5%
Gross profit$143.9M+16.0%
Operating income$38.9M+48.5%
Net income$29.5M+88.1%
EPS (diluted)$1.28+85.5%

Balance sheet

See full
Cash & equivalents$311.2M+108%
Total debt$305.3M-3.5%
Total equity$562.3M+34.3%
Total assets$1.4B+10.0%

Cash flow

See full
Operating cash flow$58.4M+66.8%
CapEx$6.1M+146%
Free cash flow$52.3M+60.8%

Valuation

See full
Market cap$1.88B+18.3%
Enterprise value$1.87B+5.8%
P/E20.4×
P/S-0.3×

Profitability

See full
Gross margin60.8%+1.5pp
Operating margin13.4%
Net margin10%+8.1pp
FCF margin20.7%+10.8pp

Returns & leverage

See full
Return on equity18.8%+15.6pp
Debt / equity0.5×-0.2×
Current ratio3.1×+0.5×

Where this comes from

Reported directly by ANI Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsGross.

The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANI Pharmaceuticals's gross carrying amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ANI Pharmaceuticals's gross carrying amount?
ANI Pharmaceuticals (ANIP) reported gross carrying amount of $936.17M in Q1 2026.
How has ANI Pharmaceuticals's gross carrying amount changed year-over-year?
ANI Pharmaceuticals's gross carrying amount increased by 2.7% year-over-year, from $911.2M to $936.17M.
What is the long-term trend for ANI Pharmaceuticals's gross carrying amount?
Over 3 years (2022 to 2025), ANI Pharmaceuticals's gross carrying amount has grown at a 24.6% compound annual growth rate (CAGR), from $480.92M to $929.87M.